Literature DB >> 19371815

Bisphosphonates--what the dentist needs to know: practical considerations.

John E Fantasia1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19371815     DOI: 10.1016/j.joms.2009.01.011

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


× No keyword cloud information.
  10 in total

1.  Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology, and Japanese Society of Oral and Maxillofacial Surgeons.

Authors:  Toshiyuki Yoneda; Hiroshi Hagino; Toshitsugu Sugimoto; Hiroaki Ohta; Shunji Takahashi; Satoshi Soen; Akira Taguchi; Satoru Toyosawa; Toshihiko Nagata; Masahiro Urade
Journal:  J Bone Miner Metab       Date:  2010-03-24       Impact factor: 2.626

2.  Bisphosphonate-associated osteonecrosis of the mandible: reliable soft tissue reconstruction using a local myofascial flap.

Authors:  Juliana Lemound; Andrè Eckardt; Horst Kokemüller; Constantin von See; Pit Jacob Voss; Frank Tavassol; Martin Rücker; Majeed Rana; Nils-Claudius Gellrich
Journal:  Clin Oral Investig       Date:  2011-08-05       Impact factor: 3.573

3.  Antibiotic effects on bacterial profile in osteonecrosis of the jaw.

Authors:  X Ji; S Pushalkar; Y Li; R Glickman; K Fleisher; D Saxena
Journal:  Oral Dis       Date:  2011-08-29       Impact factor: 3.511

4.  How concerns for bisphosphonate-induced osteonecrosis of the jaw affect clinical practice among dentists: a study from the South Texas Oral Health Network.

Authors:  Cara B Gonzales; Veronica Young; Norma S Ketchum; Jamie Bone; Thomas W Oates; Rahma Mungia
Journal:  Gen Dent       Date:  2015 Mar-Apr

Review 5.  Prevalence of dental alterations in patients under bisphosphonates therapy: a systematic review.

Authors:  Monique Abreu Pauli; Natália Cristina Trentin Bordignon; Geórgia Ribeiro Martini; Mariana Comparotto Minamisako; Rogério Gondak
Journal:  Oral Maxillofac Surg       Date:  2022-06-04

Review 6.  Is serum C-terminal telopeptide cross-link of type 1 collagen a reliable parameter for predicting the risk of medication-related osteonecrosis of the jaws? A systematic review and meta-analysis of diagnostic test accuracy.

Authors:  Bassel Traboulsi-Garet; Adrià Jorba-García; Octavi Camps-Font; Fabio Abreu Alves; Rui Figueiredo; Eduard Valmaseda-Castellón
Journal:  Clin Oral Investig       Date:  2022-02-06       Impact factor: 3.573

7.  Metagenomic investigation of microbes and viruses in patients with jaw osteonecrosis associated with bisphosphonate therapy.

Authors:  Parish P Sedghizadeh; Shibu Yooseph; Douglas W Fadrosh; Lisa Zeigler-Allen; Mathangi Thiagarajan; Hamid Salek; Farid Farahnik; Shannon J Williamson
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2012-12

8.  Bisphosphonates and osteonecrosis: an open matter.

Authors:  Paolo Vescovi
Journal:  Clin Cases Miner Bone Metab       Date:  2012-12-20

9.  Altered macrophagic THP-1 cell phagocytosis and migration in bisphosphonate-related osteonecrosis of the jaw (BRONJ).

Authors:  Sebastian Hoefert; Claudia Sade Hoefert; Adelheid Munz; Hinnak Northoff; Anna Yuan; Kathrin Reichenmiller; Siegmar Reinert; Martin Grimm
Journal:  Clin Oral Investig       Date:  2015-09-09       Impact factor: 3.573

Review 10.  Alendronate-associated osteonecrosis of the jaws: a review of the main topics.

Authors:  F Paiva-Fonseca; A-R Santos-Silva; R Della-Coletta; P-A Vargas; M-A Lopes
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2014-03-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.